Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Globalization of the pharmaceutical industry
3.2.1.2 Regulatory framework
3.2.1.3 Growing advancements in analytical instrumentations
3.2.1.4 Increasing outsourcing trends
3.2.2 Industry pitfalls & challenges
3.2.2.1 Quality concerns and risk mitigation
3.2.2.2 Confidentiality and intellectual property protection
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Service, 2018 - 2032 ($ Million)
5.1 Key trends
5.2 Bioanalytical testing
5.2.1 Clinical
5.2.2 Non-clinical
5.3 Method development & validation
5.3.1 Extractable & leachable
5.3.2 Impurity method
5.3.3 Technical consulting
5.3.4 Other method development & validation services
5.4 Stability testing
5.4.1 Drug substance testing
5.4.2 Stability indicating method validation
5.4.3 Accelerated stability testing
5.4.4 Photostability testing
5.4.5 Other stability testing services
5.5 Other services
Chapter 6 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Million)
6.1 Key trends
6.2 Active pharmaceutical ingredient (API)
6.3 Additives
6.4 Finished products
Chapter 7 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)
7.1 Key trends
7.2 Pharmaceutical companies
7.3 Biopharmaceutical companies
7.4 Academics & research institutes
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 BA Sciences
9.2 Charles River Laboratories International, Inc.
9.3 Eurofins Scientific
9.4 Immunologix Laboratories
9.5 Indoco Analytical Solutions
9.6 Intertek Group plc
9.7 Labcorp Drug Development
9.8 Pace Labs
9.9 SGS Societe Generale de Surveillance SA.
9.10 STERIS
9.11 Thermo fisher Scietific, Inc.
9.12 Triclinic Labs, Inc.
9.13 West Pharmaceutical Services, Inc.
9.14 Wuxi AppTec
